Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 3,919 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hypertension Clear all

Conditions: Ocular Hypertension
Interventions: bimatoprost/timolol fixed combination; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Diabetic Kidney Disease, Uncontrolled Hypertension
Interventions: Telehealth; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Osteoarthritis, Controlled Hypertension
Interventions: lumiracoxib; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 50 Years and older
Enrollment: 1,020 participants
Timeline: Started 2005
U.S. locations: 1
States / cities: O'Fallon, Illinois

Conditions: Iron-sulfur Cluster Deficiency, Pulmonary Hypertension, Friedreich Ataxia
Interventions: Right Heart Catheterization, Blood draw; Procedure · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 60 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Liver Cirrhosis, Hepatic Cell Carcinoma, Portal Hypertension
Interventions: Injection of a gadolinium contrast agen, Radiotracer Injection, Imaging; Drug · Diagnostic Test
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 99 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Pre-Eclampsia, Morbid Obesity, Parturient, Blood Pressure
Interventions: Non-invasive BP recording with conical Ultracheck Curve BP cuff, Non-invasive BP recording with traditional cylindrical BP cuff, Direct invasive arterial pressure; Device · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Kidney Failure, Chronic, Renal Dialysis
Interventions: Renal Denervation with a catheter-based procedure; Device
Lead sponsor: Medtronic Vascular; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Glaucoma
Interventions: VisionBlue; Other
Lead sponsor: Wills Eye; Other
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertensive Disorders of Pregnancy (HDP)
Interventions: HEART at Home; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pulmonary Hypertension
Interventions: No Intervention; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cardiovascular Diseases, Coronary Disease, Heart Diseases, Cerebrovascular Accident, Diabetes Mellitus, Hypertension, Heart Failure, Congestive
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 65 Years to 100 Years
Enrollment: 5,888 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 2027
U.S. locations: 6
States / cities: Sacramento, California • Hagerstown, Maryland • Winston-Salem, North Carolina + 3 more

Conditions: Hypertension
Interventions: Interactive Spaced Education (ISE) --- online education; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Brockton, Massachusetts

Conditions: Portal Hypertension, Cirrhosis
Interventions: HVPG, Indocyanine Green Retention test, Liver stiffness measurement, Spleen stiffness measurement; Procedure · Drug · Device
Lead sponsor: VA Connecticut Healthcare System; Federal
Eligibility: 18 Years to 85 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: New Haven, Connecticut • West Haven, Connecticut

Conditions: Hypertension
Interventions: BIO-Z, Finapres Nova; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Traumatic Brain Injury
Interventions: Mannitol, NaCl; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Hypertension
Interventions: Aliskiren, Aliskiren plus placebo; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2005
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Pre-Hypertension
Interventions: DASH-4-Teens, Routine Care; Behavioral · Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 11 Years to 18 Years
Enrollment: 207 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Hypertension, Cognitive Decline
Interventions: Tai Chi; Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: 55 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Primary Open Angle Glaucoma, Ocular Hypertension, Pseudo-Exfoliative Glaucoma, Pigment Dispersion Glaucoma
Interventions: Selective laser trabeculoplasty; Procedure
Lead sponsor: Glaucoma Research & Education Group; Other
Eligibility: 0 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2006
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension Complicated, Hypertrophy, Left Ventricular, Blood Pressure
Interventions: Valsartan 80 mg; Drug
Lead sponsor: Trinity Hypertension & Metabolic Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Carrollton, Texas

Conditions: Primary Open-Angle Glaucoma
Interventions: Stents, Laser, Laser Trabeculoplasty; Device · Procedure
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 35 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 9
States / cities: Glendale, Arizona • Fayetteville, Arkansas • Hemet, California + 6 more

Conditions: Depression, Hypertension
Interventions: Collaborations in Health (COACH); Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 60 Years and older
Enrollment: 2,685 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 4
States / cities: New Orleans, Louisiana • Ann Arbor, Michigan • Rochester, New York + 1 more

Conditions: Preeclampsia, Preeclampsia Severe, Preeclampsia Mild, Preeclampsia Postpartum
Interventions: Illustration based application, Text based application; Other
Lead sponsor: MemorialCare Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Hypertension, Pulmonary, Lung Diseases, Interstitial
Interventions: TX000045; Drug
Lead sponsor: Tectonic Operating Company, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Phoenix, Arizona • San Francisco, California • Boise, Idaho + 1 more

Search by objective public record fields.

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Integrated Population Program for Diabetic Kidney Disease

Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension

Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Non-invasive Versus Invasive Blood Pressure Measurement in the Morbidly Obese Parturient With Severe Preeclampsia

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery

Postpartum Home Visiting (HEART at Home)

Fractal Analysis of the Pulmonary Arterial Tree in Pulmonary Hypertension

Cardiovascular Health Study (CHS)

Interactive Spaced Education to Optimize Hypertension Management

Surrogate Markers of Portal Pressure

Blood Pressure Monitoring in Hypertensive Populations: Device Testing, Feasibility, Acceptability

Osmotic Therapy for Treatment of Intracranial Hypertension for Traumatic Brain Injury

Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet

Modifying Dietary Behavior in Adolescents With Elevated Blood Pressure

The Influence of Tai Chi Practice on Blood Pressure and Brain Health Among Older Adults With Hypertension (ACTION)

The Efficacy of Selective Laser Trabeculoplasty

Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH

Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

Chinese Older Adults-Collaboration in Health (COACH)Study

Preeclampsia Educational Program Study (PrEPS)

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease